SG Alba

SG Alba is a turning point in the development of parenteral primary packaging, representing the best-in-class solution for biologics. The reduced variability of materials in contact with the drug throughout its lifecycle makes our SG Alba platform the perfect solution for de-risking the development process, saving costs and securing a fast introduction to market. The drastic reduction of silicone oil particles and the extremely low-propensity to delaminate addresses some of the key requirements of protein-based drugs. Benefits: Limited underdosing concernsMitigated protein aggregationStabilized silicone layerMinimized TungstenMitigated delamination riskMinimized Extactables